Impaired Osteogenesis of Disease-Specific Induced Pluripotent Stem Cells Derived from a CFC Syndrome Patient

• Published in: International journal of molecular sciences 2017-12, Vol.18 (12), p.2591
• Main Authors: Choi, Jung-Yun, Han, Kyu-Min, Kim, Dongkyu, Lee, Beom-Hee, Yoo, Han-Wook, Choi, Jin-Ho, Han, Yong-Mahn
• Format: Article
• Language: English
• Subjects: Aberration; Activation; Alkaline phosphatase; Biocompatibility; Biomedical materials; bone development; bone morphogenetic protein (BMP); cardiofaciocutaneous syndrome; ERK; Extracellular signal-regulated kinase; Fibrosarcoma; Genetic disorders; induced pluripotent stem cells; Inhibitory postsynaptic potentials; Kinases; mesenchymal stem cells; Mesenchyme; Mineralization; Mutation; Osteoblasts; Osteogenesis; Pluripotency; Polymerase chain reaction; Skin; SMAD1; SMAD2; Smad2 protein; Stem cells; transforming growth factor-β (TGF-β); Western blotting
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms18122591

Cardiofaciocutaneous (CFC) syndrome is a rare genetic disorder caused by mutations in the extracellular signal-regulated kinase (ERK) signaling. However, little is known about how aberrant ERK signaling is associated with the defective bone development manifested in most CFC syndrome patients. In this study, induced pluripotent stem cells (iPSCs) were generated from dermal fibroblasts of a CFC syndrome patient having rapidly accelerated fibrosarcoma kinase B (BRAF) gain-of-function mutation. CFC-iPSCs were differentiated into mesenchymal stem cells (CFC-MSCs) and further induced to osteoblasts in vitro. The osteogenic defects of CFC-MSCs were revealed by alkaline phosphatase activity assay, mineralization assay, quantitative real-time polymerase chain reaction (qRT-PCR), and western blotting. Osteogenesis of CFC-MSCs was attenuated compared to wild-type (WT)-MSCs. In addition to activated ERK signaling, increased p-SMAD2 and decreased p-SMAD1 were observed in CFC-MSCs during osteogenesis. The defective osteogenesis of CFC-MSCs was rescued by inhibition of ERK signaling and SMAD2 signaling or activation of SMAD1 signaling. Importantly, activation of ERK signaling and SMAD2 signaling or inhibition of SMAD1 signaling recapitulated the impaired osteogenesis in WT-MSCs. Our findings indicate that SMAD2 signaling and SMAD1 signaling as well as ERK signaling are responsible for defective early bone development in CFC syndrome, providing a novel insight on the pathological mechanism and therapeutic targets.